Pentwater Capital Management LP
Q1 2024 13F-HR Holdings
Net value change ($000)
+840,580
(9.4%)
New positions
23
Sold out positions
36
Turnover %
45.2%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q4 2023
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| PIONEER NATURAL RESOURCES CO | 581,951 | 44.3% |
| JNP | 387,218 | NEW |
| BA | 244,673 | 152.0% |
| AKX | 241,247 | 503.6% |
| Tricon Residential Inc. | 223,000 | NEW |
| DFS | 203,190 | NEW |
| X | 177,115 | 34.9% |
| SPY | 143,260 | 172.8% |
| AHC | 132,924 | 23.7% |
| Fusion Pharmaceuticals Inc. | 80,628 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| SPLUNK INC | -618,541 | -100.0% |
| Karuna Therapeutics, Inc. | -337,463 | -100.0% |
| ImmunoGen, Inc. | -167,893 | -100.0% |
| AYXGBX | -94,320 | -100.0% |
| KVUE | -91,071 | -100.0% |
| MANU | -87,634 | -100.0% |
| TECK | -71,792 | -85.8% |
| CPRI | -57,812 | -28.8% |
| Mirati Therapeutics, Inc. | -53,030 | -100.0% |
| Olink Holding AB (publ) | -50,791 | -77.1% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
3,664,578
(37.5% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|